Literature DB >> 2046890

Treatment of cerebral arteriovenous malformations with PVA. Results and analysis of complications.

M Schumacher1, J A Horton.   

Abstract

35 Patients with cerebral arteriovenous malformations treated by endovascular embolization were analyzed. The treatment was performed in most cases with polyvinyl alcohol with additional applications of silk, coils, gelfoam or detectable balloon in some patients. 8 patients developing mild to moderate neurological deficits persisting in three patients (8.6%). No correlation of complications with history of bleeding, neurological deficit, AVM localization, AVM size, angioarchitecture, amount of occlusion and duration of the procedure could be found. Technical factors of the procedure itself are assumed to be responsible for the rate of complications.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2046890     DOI: 10.1007/bf00588243

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  10 in total

1.  Artificial embolization of cerebral arteries. Report of use in a case of arteriovenous malformation.

Authors:  A J LUESSENHOP; W T SPENCE
Journal:  J Am Med Assoc       Date:  1960-03-12

Review 2.  Update on interventional neuroradiology.

Authors:  F Viñuela; J Dion; P Lylyk; G Duckwiler
Journal:  AJR Am J Roentgenol       Date:  1989-07       Impact factor: 3.959

3.  Cerebral arteriovenous malformations: considerations for and experience with surgical treatment in 166 cases.

Authors:  C G Drake
Journal:  Clin Neurosurg       Date:  1979

4.  Preoperative embolization of brain AVMs with isobutyl-2 cyanoacrylate.

Authors:  D M Pelz; A J Fox; F Viñuela; C C Drake; G G Ferguson
Journal:  AJNR Am J Neuroradiol       Date:  1988 Jul-Aug       Impact factor: 3.825

5.  Normal perfusion pressure breakthrough theory.

Authors:  R F Spetzler; C B Wilson; P Weinstein; M Mehdorn; J Townsend; D Telles
Journal:  Clin Neurosurg       Date:  1978

6.  Endovascular treatment with isobutyl cyano acrylate in patients with arteriovenous malformation of the brain. Indications, results and complications.

Authors:  J J Merland; D Rüfenacht; A Laurent; L Guimaraens
Journal:  Acta Radiol Suppl       Date:  1986

7.  Arteriovenous malformations in the functional area: surgical treatment and regional cerebral blood flow.

Authors:  S Yamada
Journal:  Neurol Res       Date:  1982       Impact factor: 2.448

8.  Successful treatment of the normal perfusion pressure breakthrough syndrome.

Authors:  A L Day; W A Friedman; G W Sypert; J P Mickle
Journal:  Neurosurgery       Date:  1982-11       Impact factor: 4.654

9.  Natural history of arteriovenous malformations of the brain: a clinical study.

Authors:  D Fults; D L Kelly
Journal:  Neurosurgery       Date:  1984-11       Impact factor: 4.654

10.  Arteriovenous malformations of the brain: natural history in unoperated patients.

Authors:  P M Crawford; C R West; D W Chadwick; M D Shaw
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-01       Impact factor: 10.154

  10 in total
  5 in total

1.  Treatment of cerebral arteriovenous malformations by neuroradiological intervention and surgical resection.

Authors:  M Westphal; L Cristante; U Grzyska; N Freckmann; F Zanella; H Zeumer; H D Herrmann
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

2.  Superselective angiography, embolisation and surgery in treatment of arteriovenous malformations of the brain.

Authors:  P H Nakstad; H Nornes
Journal:  Neuroradiology       Date:  1994-07       Impact factor: 2.804

3.  Tailored cognitive testing with provocative amobarbital injection preceding AVM embolization.

Authors:  Lauren R Moo; Kieran J Murphy; Philippe Gailloud; Mark Tesoro; John Hart
Journal:  AJNR Am J Neuroradiol       Date:  2002-03       Impact factor: 3.825

4.  Embolization of intracranial arteriovenous malformations and fistulas with polyvinyl alcohol particles and platinum fibre coils.

Authors:  P H Nakstad; S J Bakke; J K Hald
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

5.  Hydroxyapatite ceramics as a particulate embolic material: report of the physical properties of the hydroxyapatite particles and the animal study.

Authors:  Michiya Kubo; Naoya Kuwayama; Yutaka Hirashima; Akira Takaku; Tetsuro Ogawa; Shunro Endo
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.